11/6
08:07 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
11/6
08:07 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
11/6
04:40 am
inzy
Rating for INZY
Low
Report
Rating for INZY
11/6
04:40 am
inzy
Rating for INZY
Low
Report
Rating for INZY
11/5
06:24 pm
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
11/5
06:24 pm
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock, down previously from $15.00.
10/25
08:37 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
10/25
08:37 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
10/25
06:58 am
inzy
Rating for INZY
Low
Report
Rating for INZY
10/25
06:58 am
inzy
Rating for INZY
Low
Report
Rating for INZY
9/30
08:40 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock.
Medium
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock.
9/30
08:40 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock.
Medium
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $15.00 price target on the stock.
9/30
08:17 am
inzy
Rating for INZY
Medium
Report
Rating for INZY
9/30
08:17 am
inzy
Rating for INZY
Medium
Report
Rating for INZY
9/12
08:09 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $16.00 price target on the stock.
Medium
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $16.00 price target on the stock.
9/12
08:09 am
inzy
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $16.00 price target on the stock.
Medium
Report
Inozyme Pharma, Inc. (NASDAQ: INZY) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $16.00 price target on the stock.
9/12
06:45 am
inzy
Rating for INZY
Medium
Report
Rating for INZY